Association of Adjuvant or Metastatic Setting With Discontinuation of Cancer Drugs in Clinical Trials

IMPORTANCE: Adjuvant drugs are used to reduce the risk of tumor recurrence in patients with cancer who are successfully treated with first-line therapy. The same drugs used in the metastatic or first-line setting are often used in the adjuvant setting, and although the resulting adverse effects may...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Nibras, Vengalasetti, Yasaswi, Haslam, Alyson, Prasad, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112068/
https://www.ncbi.nlm.nih.gov/pubmed/35576006
http://dx.doi.org/10.1001/jamanetworkopen.2022.12327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9112068/
https://www.ncbi.nlm.nih.gov/pubmed/35576006
http://dx.doi.org/10.1001/jamanetworkopen.2022.12327

Ejemplares similares